Hikari Tsushin Inc’s Novo Nordisk NVO Stock Holding History

Hikari Tsushin Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Hold	23,512	–	–	0.07%	49
2026 Q1	$864K	Hold	23,512	–	–	0.06%	53
2025 Q4	$1.2M	Hold	23,512	–	–	0.08%	50
2025 Q3	$1.3M	Hold	23,512	–	–	0.09%	49
2025 Q2	$1.62M	Hold	23,512	–	–	0.11%	44
2025 Q1	$1.63M	Hold	23,512	–	–	0.11%	43
2024 Q4	$2.02M	Hold	23,512	–	–	0.15%	44
2024 Q3	$2.8M	Hold	23,512	–	–	0.2%	41
2024 Q2	$3.36M	Hold	23,512	–	–	0.26%	35
2024 Q1	$3.02M	Hold	23,512	–	–	0.24%	36
2023 Q4	$2.43M	Sell	23,512 -44,455	-65%	-$4.4M	0.22%	35
2023 Q3	$6.18M	Sell	67,967 -57,973	-46%	-$5.11M	0.6%	19
2023 Q2	$10.2M	Hold	125,940	–	–	0.98%	16
2023 Q1	$10M	Hold	125,940	–	–	1.05%	15
2022 Q4	$8.52M	Hold	125,940	–	–	0.91%	16
2022 Q3	$6.27M	Hold	125,940	–	–	0.76%	18
2022 Q2	$7.02M	Hold	125,940	–	–	0.93%	16
2022 Q1	$6.99M	Hold	125,940	–	–	0.7%	19
2021 Q4	$7.05M	Buy	+125,940	New	+$6.82M	0.77%	20
2021 Q2	$5.28M	Hold	125,940	–	–	0.65%	21
2021 Q1	$4.25M	Hold	125,940	–	–	0.57%	22
2020 Q4	$4.4M	Hold	125,940	–	–	0.64%	21
2020 Q3	$4.37M	Hold	125,940	–	–	0.73%	19
2020 Q2	$4.12M	Hold	125,940	–	–	0.8%	20
2020 Q1	$3.79M	Hold	125,940	–	–	0.81%	19
2019 Q4	$3.65M	Hold	125,940	–	–	0.64%	20
2019 Q3	$3.26M	Hold	125,940	–	–	0.67%	22
2019 Q2	$3.21M	Hold	125,940	–	–	0.7%	22
2019 Q1	$3.29M	Sell	125,940 -110,620	-47%	-$2.72M	0.73%	25
2018 Q4	$5.45M	Hold	236,560	–	–	1.26%	14
2018 Q3	$5.58M	Sell	236,560 -40,000	-14%	-$976K	1.3%	13
2018 Q2	$6.38M	Hold	276,560	–	–	1.66%	8
2018 Q1	$6.81M	Hold	276,560	–	–	1.79%	6
2017 Q4	$7.42M	Hold	276,560	–	–	1.93%	5
2017 Q3	$6.66M	Hold	276,560	–	–	1.95%	6
2017 Q2	$5.93M	Hold	276,560	–	–	1.86%	6
2017 Q1	$4.74M	Hold	276,560	–	–	1.37%	10
2016 Q4	$4.96M	Sell	276,560 -276,580	-50%	-$5.01M	1.5%	8
2016 Q3	$11.5M	Hold	553,140	–	–	3.03%	8
2016 Q2	$14.9M	Hold	553,140	–	–	3.66%	5
2016 Q1	$15M	Hold	553,140	–	–	3.52%	6
2015 Q4	$16.1M	Hold	553,140	–	–	4.13%	5
2015 Q3	$15M	Sell	553,140 -61,460	-10%	-$1.74M	3.99%	5
2015 Q2	$16.8M	Sell	614,600 -63,200	-9%	-$1.78M	3.67%	5
2015 Q1	$18.1M	Hold	677,800	–	–	3.63%	5
2014 Q4	$14.3M	Hold	677,800	–	–	2.64%	9
2014 Q3	$16.1M	Sell	677,800 -21,000	-3%	-$483K	3%	7
2014 Q2	$16.1M	Hold	698,800	–	–	2.55%	10
2014 Q1	$15.9M	Hold	698,800	–	–	2.68%	8
2013 Q4	$12.9M	Buy	698,800 +30,000	+4%	+$523K	2.19%	12
2013 Q3	$11.3M	Buy	668,800 +253,000	+61%	+$4.26M	2.16%	11
2013 Q2	$6.44M	Buy	+415,800	New	+$6.92M	1.47%	15

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hikari Tsushin Inc's NVO Position: Q2 2026 in Review

Hikari Tsushin Inc held its Novo Nordisk (NVO) position steady in Q2 2026 at 23,512 shares worth $1.13M. The position accounts for 0.07% of the portfolio, ranked #49.

Hikari Tsushin Inc first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.1M in Q1 2015. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hikari Tsushin Inc held 23,512 shares of Novo Nordisk worth $1.13M as of Q2 2026.
Hikari Tsushin Inc left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.07% of Hikari Tsushin Inc's portfolio in Q2 2026, its #49 holding.
Hikari Tsushin Inc first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Hikari Tsushin Inc's Novo Nordisk position peaked at $18.1M in Q1 2015.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hikari Tsushin Inc's 13F filing for Q2 2026, filed 12 Aug 2026.